News

€8.6M grant to support first-in-man studies of its proprietary ShigETEC vaccine.

Vienna BioCenter-based biotech company PhagoMed Biopharma GmbH has discovered a novel drug candidate for the treatment of Bacterial Vaginosis and the…

PhD students Henry Thomas and Claudia Pachinger have been awarded the uni:docs Fellowships. Congratulations also to Katharina Siess and Michael…

On Thursday the 5th September 2019, the Vienna BioCenter Postdoc Symposium on Publishing Models took place. The reason for organizing it was the…

The immune system relies on B cells and their ability to make antibodies against an extremely broad range of pathogens. This broad responsiveness…

The Medical University of Vienna has nominated Anete Romanauska as Researcher of the Month. Born in Latvia, she studied Biology in Riga and later in…

Protein Kinase D (PKD) is an enzyme at the heart of many cellular functions. By modifying other proteins, it controls the trafficking of essential…

Eucodis developed and patented a catalase as a novel neutralizer in environmental monitoring media and offers either a collaboration or OEM supply of…

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,…

Emily Bayer of Columbia University, Mohamed El-Brolosy of the Max Planck Institute for Heart and Lung Research, and Justin Silpe of Princeton…

Visit the Vienna BioCenter on Friday, 11 October 2019 and learn about research opportunities at our campus.